![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
GR Luthin and BB Wolfe
The properties of [3H]quinuclidinylbenzilate ( [3H]QNB) binding and [3H]pirenzepine ( [3H]PZ) binding to various regions of rat brain were compared. [3H]PZ appeared to bind with high affinity to a single site, with a Kd value of approximately 15 nM in the cerebral cortex. The rank order of potencies of muscarinic drugs to inhibit binding of either [3H]QNB or [3H]PZ was QNB greater than atropine = scopolamine greater than pirenzepine greater than oxotremorine greater than bethanechol. Muscarinic antagonists (except PZ) inhibited both [3H]PZ and [3H]QNB binding with Hill coefficients of approximately 1. PZ inhibited [3H]QNB binding in cortex with a Hill coefficient of 0.7, but inhibited [3H]PZ binding with a Hill coefficient of 1.0. Hill coefficients for agonists were less than 1. The density of [3H]PZ binding sites was approximately half the density of [3H]QNB binding sites in cortex, striatum and hippocampus. In pons-medulla and cerebellum, the densities of [3H]PZ binding sites were 20 and 0%, respectively, relative to the densities of [3H]QNB binding sites. When unlabeled PZ was used to compete for [3H]QNB binding, the relative number of high-affinity PZ binding sites in cortex, pons and cerebellum agreed with the relative number of [3H]PZ binding sites in those regions. The binding of [3H]PZ and [3H]QNB was nonadditive in cortex. GTP inhibited high-affinity oxotremorine binding, but not PZ binding. Together, these data suggest that [3H]PZ binds to a subset of [3H]QNB binding sites. Whether this subset reflects the existence of subtypes of muscarinic receptors or is a consequence of coupling to another membrane protein remains to be seen.
This article has been cited by other articles:
|
|
 |
|
  T. Iwamoto, Y. Inoue, K. Ito, T. Sakaue, S. Kita, and T. Katsuragi The Exchanger Inhibitory Peptide Region-Dependent Inhibition of Na+/Ca2+ Exchange by SN-6 [2-[4-(4-Nitrobenzyloxy)benzyl]thiazolidine-4-carboxylic Acid Ethyl Ester], a Novel Benzyloxyphenyl Derivative Mol. Pharmacol., July 1, 2004; 66(1): 45 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-F. Jett, C. S. Ramesha, C. D. Brown, S. Chiu, C. Emmett, T. Voronin, T. Sun, C. O'Yang, J. C. Hunter, R. M. Eglen, et al. Characterization of the Analgesic and Anti-Inflammatory Activities of Ketorolac and Its Enantiomers in the Rat J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1288 - 1297. [Abstract] [Full Text]
|
|
|
|
|
|
V. P. Bakshi and M. A. Geyer Phencyclidine-Induced Deficits in Prepulse Inhibition of Startle are Blocked by Prazosin, an Alpha-1 Noradrenergic Antagonist J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 666 - 674. [Abstract] [Full Text]
|
|
|
|
|
|
D. B. Hoover and D. A. Neely Differentiation of Muscarinic Receptors Mediating Negative Chronotropic and Vasoconstrictor Responses to Acetylcholine in Isolated Rat Hearts J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1337 - 1344. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. B. M. Klaassen, W. Kuijpers, H. M. E. Scheres, J. F. R. de Miranda, and A. J. Beld Cholinergic Receptors in the Upper Respiratory System of the Rat Arch Otolaryngol Head Neck Surg, April 1, 1986; 112(4): 428 - 431. [Abstract] [PDF]
|
|
|
|
 |
|
 J. M. McIntosh, G. O. Corpuz, R. T. Layer, J. E. Garrett, J. D. Wagstaff, G. Bulaj, A. Vyazovkina, D. Yoshikami, L. J. Cruz, and B. M. Olivera Isolation and Characterization of a Novel Conus Peptide with Apparent Antinociceptive Activity J. Biol. Chem., October 13, 2000; 275(42): 32391 - 32397. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
